Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database

PURPOSE: The 21-gene recurrence score (RS) assay is currently used for predicting chemotherapeutic benefits for hormone receptor-positive (HR +) early-stage breast cancer patients without consideration regarding racial differences in that predictive value. This study aimed at demonstrating racial di...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jiwoong, Hwang, Ki-Tae, Choi, In Sil, Kim, Byoung Hyuck, Oh, Sohee, Kim, Jongjin, Park, Jeong Hwan, Park, Jin Hyun, Paek, Se Hyun, Jeon, Sook Young, Yeo, Tae-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385768/
https://www.ncbi.nlm.nih.gov/pubmed/35616777
http://dx.doi.org/10.1007/s12282-022-01371-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385768/
https://www.ncbi.nlm.nih.gov/pubmed/35616777
http://dx.doi.org/10.1007/s12282-022-01371-z

Ejemplares similares